1.Management of pre-ESRD patients.
Korean Journal of Medicine 1999;57(4):783-789
No abstract available.
Humans
2.Four Cases of Conservative Surgical Management in Major Renal Injury.
Tae Gon HWANG ; In Chul CHANG ; Moon Soo YOON ; Young Hyun PARK ; Soo Kil LIM
Korean Journal of Urology 1982;23(6):749-751
A review is presented in 4 patients with major renal injury seen in our hospital. All patients underwent conservative surgical management. A conservative surgical management to major renal injury is emphasized.
Humans
3.Lateral Extracavitary Approach to Thoracic Cord Tumor and Disc Herniation.
Sun Man KWEON ; Do Heum YOON ; Young Soo KIM
Journal of Korean Neurosurgical Society 1999;28(6):762-768
We treated 9 patients of ventrally or ventrolaterally located thoracic lesions with lateral extracavitary approach, six cases of ventrally located thoracic cord tumor, and three cases of central disc herniation. After operation, the patients' neurological symptoms were effectively improved and there were no signigicant postoperative c omplications. Compared to transthoracic approach, this approach is less invasive and enable simultaneous vertebral reconstruction and posterior spinal fixation. Although relatatively small in number experienced, lateral extracavitry approach is considered to be a alternative method to transthoracic approach for the treatment of ventrally and ventrolaterally located thoracic lesion.
Humans
4.Anti-M antibody identified in patients: 20 cases-.
Hyun Ok KIM ; Min Ja CHOI ; Seong Geun HONG ; Oh Hun KWON
Korean Journal of Blood Transfusion 1992;3(2):173-177
No abstract available.
Humans
5.Presence of anti-D in the patient with the D/u phenothype: case report.
Nam Yong LEE ; Seog Woon KWON ; Kyou Sup HAN ; Sang In KIM
Korean Journal of Blood Transfusion 1991;2(2):215-217
No abstract available.
Humans
6.Recovery of an Injured Corticoreticulospinal Tract in a Patient With Cerebral Infarct.
Sungho JANG ; Jeongpyo SEO ; Soyoung KWAK
Annals of Rehabilitation Medicine 2017;41(3):516-517
No abstract available.
Humans
7.A Study on metabolic complications in obese patients.
Yeon Soon CHA ; Yeong Sook YUN ; Sin Ye LIM ; Hye Soon PARK
Journal of the Korean Academy of Family Medicine 2000;21(10):1269-1276
No Abstract Available.
Humans
8.Clinical and psychosomatic analysis of the temporo-mandibulardisorder patient.
Journal of the Korean Association of Oral and Maxillofacial Surgeons 1992;18(4):60-72
No abstract available.
Humans
9.Lessons Learned from the Recent Past: A Personal Perspective on U.S. AIDS Policy.
Korean Journal of Preventive Medicine 1989;22(4):466-473
No abstract available.
Humans
10.Effects of Ginseng Radix on the Cell Cycle Regulation in Human Fetal Osteoblast.
Dae Gyeom KIM ; Yong Bae LEE ; Sang Kee PARK ; Hyung Keun YOU ; Kyung Tae YOU ; Yun Chul KIM ; Hyung Shik SHIN
The Journal of the Korean Academy of Periodontology 2003;33(3):415-437
Ginseng Radix(GR) had been used widely from oriental medicine and the effects of it have been investigated by many researchers. The purpose of present study was to investigate the effects of GR on the cell cycle progression and its molecular mechanism in human fetal osteoblast. The results were as follows. Increased cell proliferation was observed in cells exposed to 100 ng/ml, 10 ng/ml of GR-1 at 12 hours and 24 hours, 1 microgram/ml of GR-1 at 48 hours, and 100 microgram/ml, 10 microgram/ml of GR-2 at 12 hours, all treatment groups of GR-2 at 24 hours(p<0.05). S phase and G1 phase was increased in the group of treated with 100 ng/ml of GR-1, with 10 microgram/ml and 1 microgram/ml of GR-2, with 100 microgram/ml and 10 microgram/ml of GR-3 in the cell cycle analysis. The cell cycle regulation protein levels of Cyclin D1, Cyclin E, CDK 2, CDK 4 and CDK 6 were increased in the group of treated with 1 microgram/ml and 100 ng/ml of GR-1, with 10 microgram/ml and 1 microgram/ml of GR-2, with 100 microgram/ml and 10 microgram/ml of GR-3. On the other hand, p21 was decreased in the treatment group with 1 microgram/ml and 100 ng/ml of GR-1, with 10 microgram/ml and 1 microgram/ml of GR-2, 10 microgram/ml of GR-3, and p53 and p16 was decreased in the treatment group with 100 ng/ml of GR-1, 100 microgram/ml GR-3 and pRb was decreased in the all treatment groups except 1 microgram/ml of GR-1. These results suggested that GR increases the cell proliferation and the cell cycle progression in human fetal osteoblast, which is linked to increased cell cycle regulation protein levels of Cyclin D1, Cyclin E, CDK 2, CDK 4, CDK 6 and decreased cell cycle regulation protein levels of p21, pRb.
Humans